The FDA recently gained more leverage over pharmaceutical companies. Will it use it?

📆 25/02/2023 10:57 a. m.
📰 NPRHealth

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 63%

México Noticias Noticias

México Últimas Noticias,México Titulares

The U.S. Food and Drug Administration late last year got more leverage over pharmaceutical companies that received accelerated approvals for their drugs. How will the agency use its new powers?

Escribir Comentario

Not under the Biden administration.

Worked on TecentriqHCP startup in NSCLC for North America while at PPDCRO at the end of 2014. US_FDA approved it by 2019. Wrote so many reports for GO29436, 437, 537, 432, 431, 527 got RSI. PPD wrongfully terminated me 2017 after they injured fly_BUR in 2016. You’re welcome

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

México Últimas Noticias, México Titulares